Earlyoesophagealcancer. dr. Nina Zidar Institute of Pathology Faculty ofmedicine University of Ljubljana Slovenia

Similar documents
Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

Oesophagus and Stomach update dysplasia and early cancer

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

Gastric Cancer Histopathology Reporting Proforma

Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ

Barrett s Esophagus: Old Dog, New Tricks

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Histopathology: gastritis and peptic ulceration

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

How to treat early gastric cancer? Endoscopy

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Gastric and Oesophageal Neuroendocrine tumours. Dr Tim Bracey, Consultant Pathologist MBChB PhD MRCS FRCPath

Esophageal cancer: Biology, natural history, staging and therapeutic options

Greater Manchester & Cheshire Guidelines for Pathology Reporting of Oesophageal and Gastric Malignancy

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

CLINICAL EFFECTIVENESS

How to stage early BE cancer - EUS or endoscopic removal?

Burning Issues in the Esophagus

Carcinoma of the Urinary Bladder Histopathology

Esophageal Cancer Staging Essentials: The New TNM Staging System (7th edition) and Clinicoradiologic Implications

Gastrooesophageal reflux disease. Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia

Treatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Learning Objectives:

Gastrointestinal Tract Cancer

Upper GIT IV Gastric cancer

The esophageal submucosal glands are considered to be a continuation

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

HHS Public Access Author manuscript Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2017 March 01.

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

References. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

Handling of Upper GI Cancer Specimens

Management of pt1 polyps. Maria Pellise

A Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis

Barrett s Esophagus: Ablate Everyone?

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Paris classification (2003) 삼성의료원내과이준행

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

위 ESD 후내시경소견 성균관대학교의과대학내과이준행

Research Article Analysis of Predictors for Lymph Node Metastasis in Patients with Superficial Esophageal Carcinoma

Towards a more personalized approach in the treatment of esophageal cancer focusing on predictive factors in response to chemoradiation Wang, Da

Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1)

The pathology of bladder cancer

Carcinoma of the Renal Pelvis and Ureter Histopathology

A215- Urinary bladder cancer tissues

Prognostic analysis of gastric mucosal dysplasia after endoscopic resection: A single-center retrospective study

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

Gastroenterology Tutorial

Principles of diagnosis, work-up and therapy The Gastroenterologist s role

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

A916: rectum: adenocarcinoma

AGA SECTION. Gastroenterology 2016;150:

B Barrett neoplasia, early, endoscopic mucosal resection of, in Europe, 297

Gregory G. Ginsberg, M.D.

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Alimentary Canal (I)

Wendy L Frankel. Chair and Distinguished Professor

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

ESD for EGC with undifferentiated histology

Epithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev

Pathology in Slovenian CRC screening programme:

Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

32 Adenocarcinoma of the oesophagogastric junction

-1- Pathology Department (code: 0605) Final Exam for Third year students Date: Time allowed: 2 hours. Paper II (75 marks).

Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tract

The present staging system for esophageal carcinoma

Adenocarcinoma of the distal esophagus is a recognized

Disorders of Cell Growth & Neoplasia. Histopathology Lab

Factors for Endoscopic Submucosal Dissection in Early Colorectal Neoplasms: A Single Center Clinical Experience in China

Superficial Esophageal Neoplasms Overlying Leiomyomas Removed by Endoscopic Submucosal Dissection: Case Reports and Review of the Literature

Barrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions

A218 : Esophagus cancer tissues. (formalin fixed)

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Tumor location is a risk factor for lymph node metastasis in superficial Barrett s adenocarcinoma

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Local Excision for early rectal cancer

Imaging in gastric cancer

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Case Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination

Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours?

Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens

Definition of GERD American College of Gastroenterology

Endoscopic Submucosal Dissection ESD

Reporting HPV related carcinomas of the head and neck. dr. Nina Zidar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia

HPV and Head and Neck Cancer: What it means for you and your patients

Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett s Esophagus

BLADDER CANCER EPIDEMIOLOGY

Transcription:

Earlyoesophagealcancer dr. Nina Zidar Institute of Pathology Faculty ofmedicine University of Ljubljana Slovenia

Early carcinoma of oesophagus = tumor limited to mucosa or submucosa, not extending into muscularispropria.

AJCC (American Joint Comittee on Cancer) TNM Classification T1a:tumorsinvadinglamina propriaor muscularis mucosae T1b: tumors invading submucosa

Riskof lymphnodemetastasesin GI tract depending on the depth of invasion Depth of infiltration Colon Stomach Oesophagus Mucosa 0 2 4 % 2 3 % Submucosa 3 18 % 12 27 % 30 52 % Vieth M andstoltem. Pathologyof theearly uppergi cancer. Best Pract Res Clin Gastroenterol 2005; 19: 857-69

Staging T1 carcinoma of oesophagus M1= in situ carcinoma M2 = invasion of lamina propria M3= invasionto musc. mucosae SM1= invasionof upper thirdof submucosa SM2= invasionof middlethird of submucosa SM3= invasionof lowerthirdof submucosa Endo M and Kawano T. Detection and classification of early esophageal squamous cell cancer. Dis Esophagus 1997; 10: 155-8 Eguchi T et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer. Mod Pathol 2006; 19: 475-80

Earlycarcinomaof oesophagus

EarlySCC early adenocarcinoma! -epidemiology -etiology -behaviour -prognosis

1. EPIDEMIOLOGY

Epidemiology of oesophagealcarcinoma worldwide SCC predominates Western world: adenocarcinoma replaced SCC 6-fold increase in incidence of adenocarcinoma mild decline of SCC adenocarcinoma: the most rapidly increasing ca SCC rarely diagnosed at early stage adenocarcinoma may be detected early (endoscopic surveillance of Barrett s)

2. ETIOPATHOGENESIS

Etiology of oesophagealsquamous cell tobacco and alcohol diet genetic factors radiation achalasia carcinoma inflammatory conditions (gastritis, coeliac disease, systemic sclerosis, caustic injury) history of ca of the upper aerodigestive tract infection (aspergillus, candida, HPV)

Etiology of oesophagealsquamous cell carcinoma extensive genetic damage - field cancerization high risk for developing a second primary tumor (prevalence of 9%) synchronous carcinoma: diagnosed within 6 months after the index tumor metachronouscarcinoma: diagnosed more than 6 months after the index tumor pharyngeal or oral SCC risk for esophageal SCC Slaughter et al.»field cancerization«in oral stratified squamous epithelium: clinical implication of multicentric origin. Cancer 1953; 6: 963-8

HPV in squamous cellcarcinoma of oesophagus conflicting results prevalenceof HVP from 0% to 70% HPV may potentiallybeinvolved in oesophageal cancerogenesis useproper methodsto demonstrate transcriptionally active (integrated) virus p16 In situ hybr. E6/E7 mrna Al-HaddadS et al. Infection andesophagealcancer. Ann N Y AcadSci 2014; 1325: 187-96

Etiology of oesophagealadenocarcinoma Barrett oesophagus (95% of adenocarcinomas) gastro-oesophageal reflux disease (GERB) tobacco and alcohol obesity dietary factors inversely associated with H pylori gastritis HPV? rarely from submucosal glands and gastric heterotopia

HPV in adenocarcinoma of oesophagus HPV maybe involved in oesophageal adenocarcinoma: p16, PCR, E6/E7 mrna: high viral load in Barrett with dysplasia or carcinoma, but not in Barrett without dysplasia and in controls Rajendra S et al. Transcriptionally active human papillomavirus is strongly associated with Barrett s dysplasia and esophageal adenocarcinoma. Am J Gastroenterol 2013; 108: 1082

4. MACROSCOPICAL FEATURES

Carcinomaof oesophagus SCC: middle third adenocarcinoma: lower third

Squamous cell carcinoma of oesophagus pt1 pt2 pt3

Adenocarcinoma in Barrett s oesophagus

5. MICROSCOPICAL FEATURES

Squamous cell carcinoma of oesophagus Grade 1 Grade 2 Grade 3

Squamouscellcarcinoma Cytokeratin 5/6

Squamouscellcarcinoma p63

Oesophageal squamous cell carcinoma differential diagnosis dysplasia(intraepithelial neoplasia) invasion beyond the basement membrane desmoplasia no ancillary methods serial sections!! metastasesanddirect spread(from lungs)

Adenocarcinomaof oesophagus Intestinal, well differentiated Intestinal, poorly differentiated

Adenocarcinomaof oesophagus Diffuse type(signet ring) Mucinous(colloid)

Oesophageal adenocarcinoma differential diagnosis dysplasia(no nucleoli, no necrosis, no backto-back glands) stomach carcinoma infiltrating oesophagus CK7+ CK20±, CDX2±, mostly TTF1 - metastases and direct spread from lungs (TTF1+)

Duplicated muscularis mucosae in Barrett s oesophagus

Duplicated muscularis mucosae (musculo-fibrous anomaly) thickening of muscularis mucosae, fibrosis, extensionto lamina propria similar than in urinary bladder carcinoma specific for Barrett s oesophagus (50%-100%) not relatedto dysplasia or carcinoma may result in erroneous staging of carcinoma RubioCA, RiddellR. Musculo-fibrousanomalyin Barrett's mucosa with dysplasia. Am J Surg Pathol 1988; 12: 885-9

Duplicated muscularis mucosae in Barrett s oesophagus

Duplicated muscularis mucosae in Barrett s oesophagus Smoothelin

Duplicated muscularis mucosae in Barrett s oesophagus superficial/new muscularis mucosae new layer of lamina propria deep/true muscularis mucosae Vieth M et al. Histological analysis of endoscopic resection specimens from 326 patients with Barretts s esophagus and earyl neoplasia. Endoscopy 2004; 36: 776-81

Duplicated muscularis mucosae in Barrett s oesophagus Vesselsin newlayerbetweenlayersof duplicated muscularis mucosae Vessels in true submucosa

Staging tumors with duplicated muscularis mucosae Vieth M et al. Histological analysisofendoscopic resection specimens from 326 patients with Barretts s esophagus and earyl neoplasia. Endoscopy 2004; 36: 776-81

6. PROGNOSIS andtreatment

Prognosis ofoesophageal carcinoma Stein HJ et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005; 242: 566-73

Clinical behaviour in early oesophageal carcinoma SCC: nodal metastases in 10% of M3 tumors, and 50% of submucosal tumors (SM1-SM3) rareydiagnosed in M1 and M2 stage Adenocarcinoma: no nodal metastases in M1-M3 tumors nodal metastases in 10% of SM1 tumors and in 35% of SM3 tumors

Therapy of early oesophageal carcinoma Radical surgery: significant morbidity and mortality removal of lymph nodes Endoscopic resection: less morbidity, negligible mortality incomplete removal continuous endoscopic surveillance!

Risk stratification in early Barrett s adenocarcinoma Low-risk group: well- or moderately differentiated carcinoma no lymphovascular invasion mucosal carcinoma(m1-m3) lessthan2 cm High-risk group: poorly differentiated carcinoma lymphovascular invasion submucosal invasion (SM1-SM3) largerthan2 cm

Endoscopic mucosal resection for early carcinoma in Barett s oesophagus

Handling endoscopic mucosal resection specimens resected en bloc oriented pinned on cork or styrofoam mark deep (!) and lateral margins deep margin more important serial sections

Conclusions Differences between SCC and adenocarcinoma In adenocarcinoma, lymphatic spread occurs later and less frequently. SCC rarely diagnosed in early stage radical surgery needed in the majority of patients Intramucosal adenocarcinoma suitable for endoscopic resection Important correct histopathologic examination of EMR specimens

Thankyouforyourattention!